• search ORA
  • cwru.edu
close button

For graduate school admissions

Visit the Office of Graduate Education for info on our many doctoral programs and the graduate education application process at the School of Medicine.

For medical school admissions

Visit the Office of Admission for info on application process, financial aid, and student life.

close button

Give online to the Biomedical Sciences PhD Fund

Use our secure online giving form to make your gift to Case Western Reserve University now.

Make a difference

Find out how you can Take Three Steps to make a difference at Case Western Reserve University.

close button

Welcome to campus

Visit Case Western Reserve University's uniquely urban campus, located in the heart of Cleveland's cultural hub, University Circle. Plan your trip:


Mark R. Chance, PhD
Vice Dean for Research

School of Medicine, BRB930

Mark Chance, PhD, heads the Office of Translation and Innovation in addition to his roles as the Vice Dean for Research, Co-PI of the Clinical and Translational Science Collaborative, and the Director of the Center for Proteomics and Bioinformatics. Dr. Chance is a national leader in proteomics research and has extensive experience in collaborative projects across multiple departments and institutions. Dr. Chance is actively involved in fostering research collaborations with industry partners to accelerate translation and advance human health.  

Bill Harte, PhD
Chief Translational Officer

Center for Clinical Investigation, BRB109

Dr. Bill Harte comes to the university with more than 25 years of experience in the pharmaceutical and biotechnology industry. He was most recently the Executive Director of Chemistry Research and Discovery at Amgen, where he was responsible for technical oversight for 9 investigational new drugs. Bill specializes in oncology, inflammation and neurosciences.

Blair Geho, MD, PhD
Chief Translational Officer

Center for Clinical Investigation, BRB109

Dr. Blair Geho is the President and CEO of SDG, Inc., a Cleveland company that specializes in developing bio-nanotechnologies. Blair brings significant IND and regulatory experience with direct FDA interactions, and is an expert in nanotechnology-based delivery systems. Blair has previously been the head of Pharmaceutical Research at Proctor & Gamble, led a Phase II clinical trial, and raised significant capital for start-up companies.

Anne DeChant, MS, MBA
Manager, Special Projects

Office of Research Administration, SOM W175

Anne DeChant, MS, MBA, is the Special Projects Manager for the School of Medicine. She has worked at the SOM for over 13 years, currently as a member of the Office of the Vice-Dean for Research. Anne provides the Office of Translation and Innovation with management support for faculty projects, industry and technology liaisons, and strategic partners. Her experience with large multi-disciplinary grant applications, intellectual property, and strategic initiatives makes her uniquely qualified to manage the OTI.

Michael Haag, MS, MBA
Executive Director, Technology Management

Sears Building, room 644

Michael Haag, MS, MBA, is the university’s Executive Director of Technology Management, an office which serves all CWRU investigators with full-spectrum intellectual property management. His experiences with fostering start-up companies, partnering with industry, and developing relationships within the technology community make him a valuable partner of the OTI.

Stephanie Weidenbecher, MS, MBA
Licensing Manager, Technology Transfer Office

Sears Library, room 649

Stephanie Weidenbecher, MS, MBA, works as a licensing manager and licensing compliance officer in the Technology Transfer Office. Stephanie has been at the university for over 8 years, working closely with investigators to develop partnerships with industry and manage the life sciences portfolio at CWRU.


Contact Us

Anne DeChant

News and Announcements

Skills Development

How do I get started?

Submit an Invention Disclosure Form to the Technology Transfer Office. TTO will assess the stage of technology, commercial potential, and patentability. Then investigators can meet with the CTOs to discuss the possibility of a translation plan, develop experiments, and identify sources of funding, on-campus resources, and CROs. Finally, the team will help present your program to pharma and biotech and foster new partnerships.